NEUEHEALTH INC (NEUE) Stock Price & Overview
NYSE:NEUE • US10920V4041
Current stock price
The current stock price of NEUE is 6.753 USD. Today NEUE is up by 1.24%. In the past month the price increased by 0.49%. In the past year, price increased by 29.87%.
NEUE Key Statistics
- Market Cap
- 60.912M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -6.16
- Dividend Yield
- N/A
NEUE Stock Performance
NEUE Stock Chart
NEUE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NEUE. When comparing the yearly performance of all stocks, NEUE is one of the better performing stocks in the market, outperforming 78.48% of all stocks.
NEUE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NEUE. NEUE may be in some trouble as it scores bad on both profitability and health.
NEUE Earnings
On August 7, 2025 NEUE reported an EPS of -1.68 and a revenue of 209.08M. The company beat EPS expectations (61.7% surprise) and missed revenue expectations (-30.49% surprise).
NEUE Forecast & Estimates
7 analysts have analysed NEUE and the average price target is 7.14 USD. This implies a price increase of 5.73% is expected in the next year compared to the current price of 6.753.
For the next year, analysts expect an EPS growth of 14% and a revenue growth 28.84% for NEUE
NEUE Groups
Sector & Classification
NEUE Financial Highlights
Over the last trailing twelve months NEUE reported a non-GAAP Earnings per Share(EPS) of -6.16. The EPS decreased by -87.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NEUE Ownership
NEUE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15 | 250.148B | ||
| ELV | ELEVANCE HEALTH INC | 11.03 | 64.33B | ||
| HUM | HUMANA INC | 18.16 | 20.397B | ||
| CNC | CENTENE CORP | 10.78 | 16.917B | ||
| MOH | MOLINA HEALTHCARE INC | 17.36 | 7.18B | ||
| HQY | HEALTHEQUITY INC | 17.82 | 6.922B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 38.88 | 3.543B | ||
| PGNY | PROGYNY INC | 17.05 | 1.485B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 991.626M |
Related stock screener links
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NEUE
Company Profile
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 986 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. The NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 66-owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. The NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 42,000 value-based care consumers.
Company Info
IPO: 2021-06-24
NEUEHEALTH INC
9250 Nw 36Th Street, Suite 420
Doral FLORIDA US
Employees: 986
Phone: 16122381321
NEUEHEALTH INC / NEUE FAQ
Can you describe the business of NEUEHEALTH INC?
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 986 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. The NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 66-owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. The NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 42,000 value-based care consumers.
Can you provide the latest stock price for NEUEHEALTH INC?
The current stock price of NEUE is 6.753 USD. The price increased by 1.24% in the last trading session.
Does NEUEHEALTH INC pay dividends?
NEUE does not pay a dividend.
What is the ChartMill technical and fundamental rating of NEUE stock?
NEUE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists NEUE stock?
NEUE stock is listed on the New York Stock Exchange exchange.
What is the expected growth for NEUE stock?
The Revenue of NEUEHEALTH INC (NEUE) is expected to grow by 28.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.